Prohibits the Rhode Island medical assistance program from requiring prior authorization or a step therapy protocol for the coverage of a medication classified as an anticonvulsant or antipsychotic.

Plain-English Summary

This bill would change the rules for Rhode Island's Medicaid program (the state's health coverage for low-income residents) when it comes to two specific types of medications: anticonvulsants, which are used to treat seizures and epilepsy, and antipsychotics, which are used to treat conditions like schizophrenia, bipolar disorder, and other serious mental health conditions. Right now, Medicaid can require patients to jump through certain hoops before getting these medications covered — this bill would eliminate those hoops for these drug categories.

Specifically, the bill removes two common insurance hurdles. Prior authorization is a process where a doctor must get approval from the insurance program before a patient can receive a medication. Step therapy (sometimes called "fail first") requires patients to try cheaper or more common medications before the program will cover the one their doctor originally prescribed. This bill would prohibit Rhode Island Medicaid from using either of these requirements for anticonvulsant and antipsychotic drugs.

The people most directly affected are Rhode Island Medicaid recipients who have epilepsy, seizure disorders, schizophrenia, bipolar disorder, or other conditions treated by these medications. For these patients, the change could mean faster access to the specific medication their doctor recommends, without delays caused by administrative approval processes or being required to try alternative drugs first. Doctors treating these patients would also spend less time on paperwork and appeals related to these prescriptions.

The bill has passed the Senate and is currently being reviewed by the House Finance Committee, meaning it still needs House approval before it could become law.